Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Acta Paediatr ; 108(2): 361-366, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-29863780

RESUMEN

AIM: This study examined the clinical characteristics of central line-associated blood stream infections occurring within 30 days after insertion versus later infections in paediatric cancer patients and the subsequent risk for premature catheter removal. METHODS: This was a retrospective study of children aged 0-18 years who were diagnosed with cancer from 2013 to 2014 at the Astrid Lindgren Children Hospital, Sweden. Clinical and microbiology data for each patient were collected for 365 days after the central venous catheter (CVC) was inserted. RESULTS: During the study period, 154 children received a CVC. The overall incidence of central line associated blood stream infections was 2.0 per 1000 catheter days. A total of 108 infectious episodes were identified in 44/154 (29%) patients. Of those, 15/44 children (29%) had an early infection within 30 days and alpha-haemolytic Streptococci and coagulase-negative Staphylococci dominated. Children with early infections were more likely to have a haematological malignancy and to need premature removal of the CVC due to repeated infections. CONCLUSION: We observed a high prevalence of early CVC associated blood stream infection mainly in patients with haematological malignancies. Our study highlights the importance of preventive measures in reducing infections in paediatric cancer patients.


Asunto(s)
Bacteriemia/etiología , Cateterismo Venoso Central/efectos adversos , Adolescente , Antineoplásicos/uso terapéutico , Niño , Preescolar , Remoción de Dispositivos/estadística & datos numéricos , Humanos , Lactante , Neoplasias/tratamiento farmacológico , Estudios Retrospectivos
2.
Eur J Pediatr ; 174(6): 801-7, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25435257

RESUMEN

UNLABELLED: Clinical characteristics corroborated by laboratory investigations are essential to determine the etiology in cases of childhood neutropenia and the level of future health-care needs. Here the presentation, findings, and need of interventions in different types of neutropenia in children followed at our center from 2007 to 2012 were investigated retrospectively. Children with congenital and autoimmune neutropenia presented at a significantly younger age and with lower absolute neutrophil granulocyte counts than those with other types of neutropenia (p < 0.01-0.05). The duration of neutropenia, in case of remission, was shorter in post-infection and drug-induced cases compared to autoimmune and chronic idiopathic neutropenias (p = 0.001). Least affected from infections were children with ethnic and post-infection neutropenias compared to the others (p = 0.01-0.05). With the exception of congenital and autoimmune neutropenias, neutropenic children had few clinical infections and few hospital admissions even though the outpatient visit frequency was similar among the groups. A vast majority of the patients received no antibiotic prophylaxis. CONCLUSION: The majority of patients with pediatric neutropenia, apart from congenital types, display a benign clinical course. Our data suggest that most neutropenic children need neither antibiotic prophylaxis nor extensive medical attention.


Asunto(s)
Neutropenia/terapia , Adolescente , Antibacterianos/uso terapéutico , Niño , Preescolar , Femenino , Factor Estimulante de Colonias de Granulocitos/uso terapéutico , Humanos , Lactante , Infecciones/etiología , Masculino , Neutropenia/complicaciones , Neutropenia/diagnóstico , Estudios Retrospectivos , Centros de Atención Terciaria
3.
Pediatr Transplant ; 16(6): E241-5, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22081947

RESUMEN

DCL following hematopoietic stem cell transplantation has been reported in approximately 5% of all leukemic relapses. There have been several reports on DCL, mainly AML after umbilical cord blood transplantation. In this case study, we present a young boy diagnosed with Fanconi anemia who underwent an umbilical cord blood transplantation. Because of the graft failure, he was retransplanted one month later, also with a cord blood transplant. Two years after the second transplant, he developed AML, where 100% of the cells were of female donor origin. The donor, a now 14-yr-old female, was recently reported healthy.


Asunto(s)
Trasplante de Células Madre de Sangre del Cordón Umbilical/efectos adversos , Trasplante de Células Madre de Sangre del Cordón Umbilical/métodos , Anemia de Fanconi/complicaciones , Anemia de Fanconi/terapia , Leucemia Mieloide Aguda/etiología , Trasplante Homólogo/efectos adversos , Adulto , Niño , Preescolar , Femenino , Supervivencia de Injerto , Humanos , Lactante , Donadores Vivos , Masculino , Persona de Mediana Edad , Recurrencia , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA